Cargando…

Renal Protective Role of Xiexin Decoction with Multiple Active Ingredients Involves Inhibition of Inflammation through Downregulation of the Nuclear Factor-κB Pathway in Diabetic Rats

In Chinese medicine, Xiexin decoction (XXD) has been used for the clinical treatment of diabetes for at least 1700 years. The present study was conducted to investigate the effective ingredients of XXD and their molecular mechanisms of antidiabetic nephropathy in rats. Rats with diabetes induced by...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Jia-sheng, Shi, Rong, Zhong, Jie, Lu, Xiong, Ma, Bing-liang, Wang, Tian-ming, Zan, Bin, Ma, Yue-ming, Cheng, Neng-neng, Qiu, Fu-rong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3713598/ https://www.ncbi.nlm.nih.gov/pubmed/23935673 http://dx.doi.org/10.1155/2013/715671

Ejemplares similares

Combination of Active Components of Xiexin Decoction Ameliorates Renal Fibrosis Through the Inhibition of NF-κB and TGF-β1/Smad Pathways in db/db Diabetic Mice
por: Wu, Jia-Sheng, et al.
Publicado: (2015)

Anti-Apoptotic Role of Sanhuang Xiexin Decoction and Anisodamine in Endotoxemia
por: Liu, Zixuan, et al.
Publicado: (2021)

Efficacy of Banxia Xiexin decoction for chronic atrophic gastritis: A systematic review and meta-analysis
por: Cao, Yang, et al.
Publicado: (2020)

Sanhuang Xiexin decoction promotes good functional outcome in acute ischemic stroke
por: Song, Juexian, et al.
Publicado: (2018)

Banxia Xiexin decoction: A review on phytochemical, pharmacological, clinical and pharmacokinetic investigations
por: Zhou, Zehua, et al.
Publicado: (2023)

Investigation of Molecular Mechanism of Banxia Xiexin Decoction in Colon Cancer via Network Pharmacology and In Vivo Studies
por: Ma, Lili, et al.
Publicado: (2022)

Herbal medicine (Gancao Xiexin decoction) for Behcet disease: A systematic review protocol
por: Wu, Dongjie, et al.
Publicado: (2018)

Acute and subacute oral toxicity assessment of Gancao Xiexin decoction in Sprague-Dawley rats
por: Ru, Li, et al.
Publicado: (2023)

Modified Banxia Xiexin Decoction Ameliorates Polycystic Ovarian Syndrome With Insulin Resistance by Regulating Intestinal Microbiota
por: Zhao, Hongyu, et al.
Publicado: (2022)

Gancao Xiexin Decoction Ameliorates Ulcerative Colitis in Mice via Modulating Gut Microbiota and Metabolites
por: Luo, Yi-ting, et al.
Publicado: (2022)

Exploration of Gancao Xiexin decoction for treatment of Behcet disease based on network pharmacology and molecular docking
por: Zhang, Xin
Publicado: (2022)

Integrated serum pharmacochemistry and metabolomics reveal potential effective components and mechanisms of Shengjiang Xiexin decoction in the treatment of Clostridium difficile infection
por: Cui, Yutao, et al.
Publicado: (2023)

Gancao Xiexin decoction combined with mesalazine in the treatment of ulcerative colitis: A protocol for a systematic review and meta-analysis
por: Zhong, Chun, et al.
Publicado: (2020)

Banxia Xiexin Decoction in the treatment of chronic atrophic gastritis: A protocol for systematic review and meta-analysis
por: Ji, Qing, et al.
Publicado: (2020)

Effectiveness of Banxia Xiexin Decoction in the treatment of precancerous lesions: A protocol for systematic review and meta-analysis
por: Yi, Ying, et al.
Publicado: (2021)

Efficacy and Safety of Banxia XieXin Decoction, a Blended Traditional Chinese Medicine, as Monotherapy for Patients With Advanced Hepatocellular Carcinoma
por: Wang, Lijuan, et al.
Publicado: (2020)

Elucidation of the Mechanisms and Molecular Targets of Sanhuang Xiexin Decoction for Type 2 Diabetes Mellitus Based on Network Pharmacology
por: Xu, Manman, et al.
Publicado: (2020)

Banxia Xiexin Decoction in the treatment of Hp-associated peptic ulcer: A protocol for systematic review and meta-analysis
por: Zhu, Weikai, et al.
Publicado: (2021)

Treatment of the Gastroesophageal Reflux Disease with Chinese Herbal Medicine (BanxiaXiexin Decoction): Evidence from Meta-Analysis
por: Liu, Jiali, et al.
Publicado: (2022)

Shengjiang Xiexin Decoction Alters Pharmacokinetics of Irinotecan by Regulating Metabolic Enzymes and Transporters: A Multi-Target Therapy for Alleviating the Gastrointestinal Toxicity
por: Guan, Huan-yu, et al.
Publicado: (2017)

Efficacy and Safety of Modified Banxia Xiexin Decoction (Pinellia Decoction for Draining the Heart) for Gastroesophageal Reflux Disease in Adults: A Systematic Review and Meta-Analysis
por: Dai, Yunkai, et al.
Publicado: (2017)

Renal sympathetic denervation improves myocardial apoptosis in rats with isoproterenol-induced heart failure by downregulation of tumor necrosis factor-α and nuclear factor-κB
por: Yao, Wei, et al.
Publicado: (2017)

Preventive Effects of a Chinese Herbal Formula, Shengjiang Xiexin Decoction, on Irinotecan-Induced Delayed-Onset Diarrhea in Rats
por: Deng, Chao, et al.
Publicado: (2017)

Banxia Xiexin Decoction Is Effective to Prevent and Control Irinotecan-Induced Delayed Diarrhea in Recurrent Small Cell Lung Cancer
por: Lu, Hongyang, et al.
Publicado: (2018)

Analysis of the pharmacological mechanism of Banxia Xiexin decoction in treating depression and ulcerative colitis based on a biological network module
por: Yu, Ying, et al.
Publicado: (2020)

Efficacy and safety of Banxia Xiexin Decoction as a complementary treatment for gastric cancer: A protocol for systematic review and meta-analysis
por: Zhang, Meiqing, et al.
Publicado: (2021)

Mechanisms of Banxia Xiexin Decoction Underlying Chronic Atrophic Gastritis via Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulations
por: Chang, Cheng, et al.
Publicado: (2022)

Electroacupuncture Attenuates Inflammation after Ischemic Stroke by Inhibiting NF-κB-Mediated Activation of Microglia
por: Liu, Rong, et al.
Publicado: (2020)

Banxia Xiexin Decoction Ameliorates t-BHP-Induced Apoptosis in Pancreatic Beta Cells by Activating the PI3K/AKT/FOXO1 Signaling Pathway
por: Du, Li-juan, et al.
Publicado: (2020)

Yiguanjian decoction and its ingredients inhibit angiogenesis in carbon tetrachloride-induced cirrhosis mice
por: Zhou, Ya-Ning, et al.
Publicado: (2015)

Simultaneous determination of 14 active constituents of Shengjiang Xiexin decoction using ultrafast liquid chromatography coupled with electrospray ionization tandem mass spectrometry
por: Peng, Gang, et al.
Publicado: (2017)

Banxia Xiexin Decoction Inhibits the Expression of PD-L1 Through Multi-Target and Multi-Pathway Regulation of Major Oncogenes in Gastric Cancer
por: Feng, Xuan, et al.
Publicado: (2021)

Traditional Banxia Xiexin decoction inhibits invasion, metastasis, and epithelial mesenchymal transition in gastric cancer by reducing lncRNA TUC338 expression
por: Dai, Xiaojun, et al.
Publicado: (2023)

Banxia Xiexin decoction ameliorated cognition via the regulation of insulin pathways and glucose transporters in the hippocampus of APPswe/PS1dE9 mice
por: Chen, Fang, et al.
Publicado: (2018)

Efficacy of modified Banxia Xiexin decoction in the management of Wei-Pi syndrome (postprandial distress syndrome): study protocol for a randomized, waitlist-controlled trial
por: Sin, Sai Ho, et al.
Publicado: (2021)

[(2S)-2-(3,5-Dichloro-2-oxidobenzylideneamino)-3-(4-hydroxyphenyl)propionato-κ(3) O,N,O′](dimethylformamide-κO)copper(II)
por: Tan, Ming-Xiong, et al.
Publicado: (2008)

[(E)-2-(3,5-Dibromo-2-oxidobenzylideneamino)-3-(4-hydroxyphenyl)propionato-κ(3) O,N,O′](dimethylformamide-κO)copper(II)
por: Tan, Ming-Xiong, et al.
Publicado: (2008)

Volatile components in Yinchenzhufu decoction and their pharmacokinetics after oral administration in rats
por: Zan, Bin, et al.
Publicado: (2022)

Nuclear Factor κB (NF-κB)–Mediated Inflammation in Multiple Sclerosis
por: Zhou, Yifan, et al.
Publicado: (2020)

Identifying Bioactive Ingredients and Antioxidant Activities of Wild Sanghuangporus Species of Medicinal Fungi
por: Wang, Hao, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qr18lo68nksnofgiutbuii53ks